Abstract
We have translated a powerful genetic tool, designer receptors exclusively activated by designer drugs (DREADDs), from mammalian systems to Drosophila melanogaster to selectively, rapidly, reversibly, and dose-dependently control behaviors and physiological processes in the fly. DREADDs are muscarinic acetylcholine G protein-coupled receptors evolved for loss of affinity to acetylcholine and for the ability to be fully activated by an otherwise biologically inert chemical, clozapine-N-oxide. We demonstrate its ability to control a variety of behaviors and processes in larvae and adults, including heart rate, sensory processing, diurnal behavior, learning and memory, and courtship. The advantages of this particular technology include the dose-responsive control of behaviors, the lack of a need for specialized equipment, and the capacity to remotely control signaling in essentially all neuronal and nonneuronal fly tissues.
Document Type
Article
Publication Date
9-12-2013
Digital Object Identifier (DOI)
http://dx.doi.org/10.1016/j.celrep.2013.08.003
Repository Citation
Becnel, Jaime; Johnson, Oralee; Majeed, Zana R; Tran, Vi; Yu, Bangning; Roth, Bryan L.; Cooper, Robin L.; Kerut, Edmund K.; and Nichols, Charles D., "DREADDs in Drosophila: a Pharmacogenetic Approach for Controlling Behavior, Neuronal Signaling, and Physiology in the Fly" (2013). Biology Faculty Publications. 46.
https://uknowledge.uky.edu/biology_facpub/46
Notes/Citation Information
Published in Cell Reports, v. 4, no. 5, p. 1049-1059.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.